InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
50%
T+90 mean return
-0.7%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by PATEL DINESH V PH D, Chief Executive Officer. Officer active across 1 company, notably Protagonist Therapeutics, Inc. In total, 30 filings have been logged. Split: 0 buy · 8 sells. Total volume traded: €8.6m. History available since 21 September 2021. The latest transaction was disclosed on 12 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations30 total
75,000 shares@ US$21.580.025% mcap32.5% of flowCommon StockSEC:0001104659-26-061476
75,000 shares@ US$21.580.025% mcap32.5% of flowCommon StockSEC:0001104659-26-061476:0
24,000 shares@ US$4.210.8% of flowCommon StockSEC:0001104659-25-021045:0
5,359 shares@ US$38.181.6% of flowCommon StockSEC:0001104659-25-015734:0
12,636 shares0Common StockSEC:0001104659-25-004570:0
149,800 shares0Common StockSEC:0001104659-25-001429:0
78,520 shares@ US$46.9627.9% of flowCommon StockSEC:0001104659-24-123806:0
1,000 shares0Common StockSEC:0001104659-24-121501:0
1,000 shares0Common StockSEC:0001104659-24-072307:0
35,000 shares@ US$35.199.0% of flowCommon StockSEC:0001104659-24-070419:0
25,000 shares@ US$28.315.2% of flowCommon StockSEC:0001104659-24-042744:0
30,000 shares@ US$31.627.0% of flowCommon StockSEC:0001104659-24-030159:0
10,915 shares@ US$29.532.4% of flowCommon StockSEC:0001104659-24-028888:0
3,717 shares@ US$28.230.8% of flowCommon StockSEC:0001104659-24-025685:0
84,875 shares0Common StockSEC:0001104659-24-001492:0
75,000 shares@ US$20.0811.1% of flowCommon StockSEC:0001104659-23-126419:0
6,000 shares@ US$4.210.2% of flowCommon StockSEC:0001104659-23-110157:0
10,000 shares0Common StockSEC:0001104659-23-067690:0
3,000 shares0Common StockSEC:0001104659-23-004721:0
20,000 shares@ US$4.210.7% of flowCommon StockSEC:0000899243-22-029621:0
15,742 shares@ US$4.210.0011% mcap1.5% of flowCommon StockSEC:0001104659-22-055995:0
30,000 shares@ US$4.210.0022% mcap2.8% of flowCommon StockSEC:0001104659-22-050551:0
34,087 shares@ US$1.890.0011% mcap1.4% of flowCommon StockSEC:0001104659-22-046158:0
4,648 shares@ US$24.280.0018% mcap2.4% of flowCommon StockSEC:0001104659-22-029520:0
31,250 shares0Common StockSEC:0001104659-22-024835
25 of 30 declarations
About PATEL DINESH V PH D
Dinesh V. Patel, Ph.D. is the President and CEO of Protagonist Therapeutics, Inc. He leads the company in its strategic and operational activities, focusing on innovation in drug development. His expertise in the biopharmaceutical sector is essential for guiding the growth and development of Protagonist.
